Table 1 Patients’ demographical and clinical characteristics
Whole cohort (n = 32) | Responders (n = 23) | Non-responders (n = 9) | |
|---|---|---|---|
Age in years, mean (SD) | 56.9 (± 14.3) | 56.9 (± 15.5) | 57.0 (± 11.5) |
Gender, n (% F) | 22 (68.7) | 18 (78.2) | 4 (44.5) |
Education in years, mean (SD) | 8.0 (± 2.9) | 8.0 (± 3.1) | 8.6 (± 2.3) |
BMI, mean (SD) | 26.8 (± 5.3) | 27.0 (± 5.8) | 27.1 (± 4.0) |
Smokers, n (%) | 10 (31.2) | 7 (30.4) | 3 (33.4) |
MADRS at T0, mean (SD) | 33.4 (± 7.4) | 33.0 (± 7.2) | 34.1 (± 8.7) |
MADRS at T1, mean (SD) | 11.0 (± 10.0) | 5.5 (± 3.9) | 25.0 (± 6.1) |
Delta% MADRS at T1, mean (SD) | 65.9 (± 29.6) | 82.2 (± 11.8) | 24.2 (± 17.5) |
Psychotic symptoms, n (%) | 23 (71.8) | 16 (69.5) | 7 (77.8) |
Recurrent MDD, n (%) | 29 (90.6) | 20 (86.9) | 9 (100) |
Comorbidity with personality disorders, n (%) | 6 (18.8) | 3 (33.3) | 3 (13.0) |
Comorbidity with anxiety disorders, n (%) | 3 (9.4) | 3 (13.0) | 0 (0.0) |
ECT sessions, mean (SD) | 7.4 (2.2) | 7.0 (1.7) | 8.2 (3.2) |